Next Article in Journal
Gene Mutations of the Three Ectodysplasin Pathway Key Players (EDA, EDAR, and EDARADD) Account for More than 60% of Egyptian Ectodermal Dysplasia: A Report of Seven Novel Mutations
Previous Article in Journal
The PUB4 E3 Ubiquitin Ligase Is Responsible for the Variegated Phenotype Observed upon Alteration of Chloroplast Protein Homeostasis in Arabidopsis Cotyledons
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 12
Issue 9
10.3390/genes12091388
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review

by
Ji Yoon Han
1 and
Joonhong Park
2,3,*
1
Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
2
Department of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Korea
3
Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Korea
*
Author to whom correspondence should be addressed.
Genes 2021, 12(9), 1388; https://doi.org/10.3390/genes12091388
Submission received: 6 August 2021 / Revised: 30 August 2021 / Accepted: 1 September 2021 / Published: 7 September 2021
(This article belongs to the Section Human Genomics and Genetic Diseases)
Browse Figures
Versions Notes

Abstract

:
The terminal 14q32 duplication has been reported often in association with other cytogenetic abnormalities, and individuals with this specific duplication showed varying degrees of developmental delay/intellectual disability (DD/ID) and growth retardation (GR), and distinct facial dysmorphisms. Herein, based on the limited cases of terminal duplication of 14q32 known to date, we present new affected siblings presenting with DD/ID, GR, and facial dysmorphism, as well as cerebral infarction caused by recurrent de novo der(14)t(14;14)(p11.2;q32.1) leading to terminal duplication of 14q32. We used coverage analysis generated via duo exome sequencing, performed chromosomal microarray (CMA) as a confirmatory test, and compared our findings with those reported previously. Coverage analysis generated via duo exome sequencing revealed a 17.2 Mb heterozygous duplication at chromosome 14q32.11-q32.33 with a Z ratio ranging between 0.5 and 1 in the proband and her elder brother. As a complementary method, CMA established a terminal duplication described as the arr[hg19]14q32.11q32.33(90,043,558_107,258,824)x3 in the proband and her elder brother; however, the parents and other siblings showed normal karyotyping and no abnormal gain or loss of CMA results. Five candidate genes, BCL11B, CCNK, YY1, DYNC1H1, and PACS2, were associated with the clinical phenotypes in our cases. Although the parents had normal chromosomes, two affected cases carrying terminal duplication of 14q32 can be explained by gonadal mosaicism. Further studies are needed to establish the association between cerebrovascular events and terminal duplication of chromosome 14q32, including investigation into the cytogenetics of patients with precise clinical descriptions.

1. Introduction

Chromosome 14 is an acrocentric chromosome. Its short arm consists of only of the satellite that is extremely gene-poor and involved in various chromosomal rearrangement, including translocation. The finished sequence of human chromosome 14 comprises 87,410,661 base pairs, representing 100% of its euchromatic portion, in a single continuous segment covering the entire long arm with no gaps. The segment contains between 800 and 1300 genes and constitutes nearly 3.5 percent of the total cellular DNA [1]. On the other hand, chromosomal abnormalities are a significant cause of human genetic disorders and are associated with various complex traits [2]. Particularly, the karyotype imbalance occurs in cases of numerical anomalies, such as missing one (or more) chromosome(s) (monosomy) or excess (trisomy). Otherwise, disproportionate structural changes occur due to deletion or duplication of chromosome segment(s). In an unbalanced chromosomal aberration, the chromosomal complement carries an incorrect number of chromosomal components, leading to serious and multiple congenital anomalies [3]. Duplication is one of the structural alterations underlying the imbalance. Duplications involve repetition of a segment of chromosome once or several times, depending on whether the duplicated segments lie in the same orientation (tandem) or become flipped (inverted). Duplications can lead to an increased copy number of genes and an associated increase in their expression [4].
To date, the various segments of abnormal rearrangements in 14q have been reported [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49], and the terminal 14q32 duplication has been reported often in association with other cytogenetic abnormalities [7,8,11,43,47]. The genotype/phenotype correlations remain unclear, despite success in previous studies [39,42,43,47,49]. Individuals with this specific duplication showed varying degrees of developmental delay/intellectual disability (DD/ID) and growth retardation (GR), and distinct facial dysmorphisms [39,42,43,47,49]. Herein, based on the limited cases of terminal duplication of 14q32 known to date, we present new affected siblings presenting with DD/ID, GR, and facial dysmorphism, as well as cerebral infarction (CI) caused by recurrent de novo der(14)t(14;14)(p11.2;q32.1) leading to terminal duplication of 14q32. We used coverage analysis generated via duo exome sequencing, performed chromosomal microarray (CMA) as a confirmatory test, and compared our findings with those reported previously.

2. Materials and Methods

2.1. Duo Exome Sequencing of Two Affected Siblings

To identify the possible genetic causes of CI, growth retardation, and/or ID in patients, the exomic DNA of two affected siblings were amplified using Agilent’s SureSelect XT Human All Exon v5 (Agilent Technologies, Santa Clara, CA, USA). Based on suspected neurodevelopmental diseases, paired-end sequencing was performed to identify the genetic alterations using the Illumina NextSeq 550 System (Illumina, San Diego, CA, USA) at the Green Cross Genome (Yongin, Korea). Base calling, quality check, read alignment, variant calling, and variant annotation for functional interpretation of results were carried out according to GATK Best Practices workflow for germline short variant discovery (https://gatk.broadinstitute.org/hc/en-us; accessed on 22 August 2020). Interpretation of sequence variants was reviewed manually by medical laboratory geneticists based on the Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology standards and guidelines [50]. The inclusion criteria for candidate variants expected to be associated with clinical manifestations were: read depth > 30×, Phred quality score > 20, absence of Fisher strand bias, allele frequency < 0.01%, indel or nonsynonymous base changes occurring at the exon–intron boundaries or coding region, dominant heterozygous, compound heterozygous, or homozygous recessive status in both siblings, and previously associated with DD/ID, GR, facial dysmorphism, and/or CI in the Clinvar (https://www.ncbi.nlm.nih.gov/clinvar/; accessed on 2 April 2021) or Online Mendelian Inheritance in Man (OMIM, https://www.omim.org/; accessed on 2 April 2021) databases. All candidate variants were confirmed visually using an Integrative Genomics Viewer followed by Sanger sequencing with ABI3500XL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). In addition, copy number variations (CNVs) are a source of human genetic alteration and have been reported previously as a genetic cause of unexplained DD/ID, GR, facial dysmorphism, and/or CI [51,52,53]. VisCap, inference and visualization tool of germline CNVs from targeted clinical sequencing data, were used for additional depth-of-coverage analysis of exome sequencing data [54].

2.2. Chromosomal Microarray

To validate the CNV detected by depth-of-coverage analysis using exome sequencing, a whole genomic screening of chromosomal rearrangements by CMA was performed using SurePrint G3 Human CGH + SNP Microarray 4×180K (Agilent Technologies, Santa Clara, CA, USA), according to the manufacturers’ protocol. All the samples were matched with Human Genomic DNA reference (Agilent Technologies or Promega, Madison, WI, USA). Data were acquired using the Agilent Feature Extraction software 12.0.2.2 and Agilent CytoGenomics 4.0 and inspected visually using the Agilent Genomic Workbench Software 7.0.4.0 and Agilent CytoGenomics 4.0. Genomic locations were mapped using the human genomic reference sequence GRCh37/hg19. CNVs were classified using the ADM-2 algorithm with a minimum size filter cut-off of 200 Kb for copy number gains or losses in the region, and a minimal absolute average log2 ratio of 0.25 as the cut-off, copy number gain (0.25), or loss (−0.25) for heterozygous regions.

3. Case Presentation

The 14-year-old female proband (II-4 in Figure 1A) presented with acute left arm weakness and was referred to the Department of Pediatric Neurology, Daejeon St. Mary’s Hospital (Daejeon, Korea). On admittance, she was diagnosed with severe DD/ID with an intelligence quotient (IQ) of 40 and GR similar to her elder brother (II-3 in Figure 1A). She was born uneventfully to healthy, unrelated Korean parents after a normal pregnancy. Birth weight was 2750 g (20th percentile) and head circumference was 33 cm (25th percentile). Prenatal history was unremarkable. The patient’s height was 99 cm (<3 percentile), weight was 14 kg (<3 percentile), and head circumference was 51 cm (<3 percentile) at 14 years of age. Her early development was markedly delayed. She could not utter a single word and used some onomatopoeic words. She performed head control at 6 months and walked independently at 30 months. She showed a dysmorphic face, including frontal bossing, widely spaced teeth, broad upper alveolar ridges, broad mouth, downturned corners of the mouth, broad nasal root, and deep nasal bridge. She carried sparse hair, eyelashes, and eyebrows. She did not develop secondary sexual characteristics, such as breast enlargements or pubic hair, until the age of 18. Levels of growth and sex hormones were low, whereas other pituitary hormones were within normal range. On physical examination, cardiac auscultation revealed high-pitched sounds, and an early diastolic decrescendo murmur heard best at the third intercostal space on the left. She had atopic dermatitis of the inside crease of the elbow, popliteal areas, face, and neck. Brain magnetic resonance imaging (MRI) revealed acute infarction in the right striatocapsular region and cortical areas of right temporal lobe (a and b in Figure 1B). MR angiography showed that the M1 segment of the middle cerebral artery (MCA) was occluded and distal MCA retrograde filled by leptomeningeal collaterals (c in Figure 1B). Cervical spine radiography indicated no cervical subluxation or cervical abnormality (d in Figure 1B). Thoracic and transesophageal echocardiogram revealed severe aortic regurgitation (AR) with mild aortic stenosis (AS) and dilated ascending aorta. Thrombotic profiles including homocysteine, antithrombin III, protein C and S activities, activated protein C resistance, factor V Leiden, Factors II, VII, VIII, and X, and plasminogen activity were within the normal range. Immunological tests including lupus anticoagulant, anticardiolipin antibodies, antinuclear antibodies, antiphospholipid antibodies, anti-SS-A/B antibodies, and ANCA were negative. Routine laboratory and radiology tests were within normal limits and other metabolic parameters, including amino acid levels, organic acids, lactate/pyruvate, thyroid hormones, and α-galactosidase were within normal ranges. Fragile X testing was negative. However, chromosomal analysis revealed de novo 46,XX,der(14)t(14;14)(p11.2;q32.1) according to the guidelines of the International System for Human Cytogenomic Nomenclature (ISCN, 2016) (Figure 2A). The patient was managed conservatively with intravenous fluids, mannitol, and dexamethasone and started on aspirin (100 mg daily) for secondary stroke prevention. Weakness gradually improved, and the patient regained normal health status after 1 month. She was administered enalapril for AR treatment.
The proband’s elder brother (II-3 in Figure 1A) visited the Department of Pediatric Neurology, Daejeon St. Mary’s Hospital for genetic counseling and segregation analysis at the age of 19 years. On admittance, he was also diagnosed with severe DD/ID, IQ of 50, and GR. He was born via normal spontaneous delivery at 38 + 1 weeks of gestation. His birth weight was 2800 g (25th percentile), and his head circumference was 33 cm (25th percentile). He manifested left hemiparesis after birth and persistent left arm weakness. He could control his head well at the age of 7 months and roll over at the age of 11 months. He sat independently at 15 months, crawled at 19 months, and stood at 23 months. Walking was accomplished at the age of 30 months. Speech was limited to pronouncing just his names at the age of 4. His weight at 19 years of age was 25 kg (<third percentile) and height 119 cm (<third percentile). The face showed slightly coarse features with widely spaced teeth, broad mouth, downturned corners of the mouth, broad nasal root, and deep nasal bridge. He could only speak a few words. He did not show any secondary sexual characteristics, including pubic hair, deepening of voice, or increased muscle mass and strength, at the age of 20. The levels of growth and sex hormones were low, whereas other pituitary hormones were within the normal range. Brain MRI showed dysgenesis of the corpus callosum, and the right hemisphere was abnormally smaller than the other (a–d in Figure 1C). Laboratory tests such as thyroid function and metabolic profiles, and radiologic findings were normal. Fragile X testing was negative. However, chromosomal analysis revealed de novo 46,XY,der(14)t(14;14)(p11.2;q32.1) similar to the proband according to the guidelines of the ISCN (Figure 2B).

4. Results

On-target yields of 3,293,954,491 and 3,127,800,131 reads were generated from the proband and her elder brother based on the quality of all sequences. The mean read depths (×) were 65 and 62, and the percentage of bases above 30× was 81% and 85%, respectively. As a result, heterozygous variants of the two candidate genes associated with DD/ID, GR, or facial dysmorphism were identified via duo exome sequencing in both the proband and her elder brother: FRMD4A (NM_018027.4: c.2296G>A/p.Ala766Thr) located on chr10:13,699,293 related to corpus callosum, agenesis, with facial anomalies, cerebellar ataxia (OMIM ID: #616819), and TBX1 (NM_080647.1: c.1480C>G/p.Pro494Ala) located on chr22:19,754,382 related to conotruncal anomaly face syndrome (OMIM ID: #217095). On the other hand, coverage analysis generated via duo exome sequencing revealed a 17.2 Mb heterozygous duplication at chromosome 14q32.11-q32.33 with a Z ratio ranging between 0.5 and 1 in the proband and her elder brother (Figure 3A). As a complementary method, CMA established a terminal duplication from 14q32.11 to 14qter described as the arr[hg19]14q32.11q32.33(90,043,558_107,258,824)x3 in the proband and her elder brother, similar to the de novo der(14)t(14;14)(p11.2;q32.1) by chromosomal analysis (Figure 3B). To investigate its genetic origin in recurrent der(14)t(14;14)(p11.2;q32.1), genetic counseling and segregation analysis of parents and other siblings of the proband was performed. However the parents and other siblings showed normal karyotyping and no abnormal gain or loss of CMA results. CMA ratio plots for chromosome 14 revealed no imbalance in both parents of the proband. In addition, heterozygous variants of the two protein-coding genes located on chromosome 14q32.11-q32.33 were identified by duo exome sequencing in both the proband and her elder brother: BEGAIN (NM_020836.3:c.1195A>G/p.Ser399Gly; rs753726540) located on chr14:101,004,893 and AHNAK2 (NM_138420.2:c.10856G>A/p.Arg3619Gln; rs752295555) located on chr14:105,410,932.

5. Discussion

Chromosome 14, one of five acrocentric chromosomes in the human genome, contains a heterochromatic short arm carrying ribosomal RNA genes essentially, and a euchromatic long arm in which most of the protein-coding genes are located. Phenotypic heterogeneity has been observed in children with partial duplication of various chromosomal segments. Whenever a larger or more distal segment of the long arm was involved, clinical features tended to be more severe. However, it is not clear whether substantial phenotypic variations between patients were due in part to individual differences, environmental factors, and the size of the trisomic segment, or the associated partial trisomy [55,56]. Duplication of the distal segment was not strongly linked to a well-described syndrome. Particularly, the chromosomal abnormality affecting the proximal segment of 14q has been commonly reported, while terminal 14q32 duplication is rarely associated with the monosomic segment of other chromosomes. Since Allerdice et al. first reported a case of partial trisomy of 14q [5], a few live-born patients have been published. Distal trisomy 14 is rarer than proximal trisomy 14, and full trisomy 14 most often causes stillbirth. Several cases involve DECIPHER’s genome database, with a brief phenotypic description (https://decipher.sanger.ac.uk/; accessed on 2 April 2021), and approximately 20 cases of pure 14q duplication are reported in the literature [14,28,31,34,39,40,42,44,45,47,48,49]. Despite the rarity of terminal 14q32 duplication, a distinct phenotype characterized by low birth weight, GR, DD/ID, hypotonia, and facial dysmorphisms has emerged. A systematic literature review of clinical features and frequencies in 45 reported cases with 14q duplication was conducted [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49] (Supplementary Table S1). The unique phenotype was characterized by DD/ID (98%), low birth weight (60%), GR (36%) (blue bars in Figure 4), and facial dysmorphisms, including downslanting palpebral fissure, hyperteolorism, broad and/or flat nasal bridge, micrognathia, low-set ear, and sparse eyebrows and eyelashes (green bars in Figure 4). The frequently accompanying clinical manifestations include brain anomalies (22%), cardiac anomalies (33%), digital anomalies (36%) involving organ systems (orange bars in Figure 4), hypotonia (36%), and skeletal abnormalities (31%), among other conditions (grey bars in Figure 4).
On the other hand, duplication of 14q occurs as a result of various chromosomal structural aberrations, such as translocation, tandem duplication, inversion, or insertion [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]. In most reported cases (69%), the abnormal chromosome segment resulted from a carrier parent. In 24 cases (57%), the 14q duplication is attributed to parental translocation (83%) and is associated with partial monosomy. The origin translocation was paternal in 17 cases (50%) and maternal in 17 cases (50%). De novo translocation was observed in five cases (17%), including our patients. Balanced reciprocal translocations and their unbalanced offspring have been reported for the first time [6]. In most cases, the unbalanced karyotype was the result of genetic duplication or translocation deficiency of the chromosomes derived from the parents. Pericentric inversion occurred in about 10% of patients. Pericentric inversions of chromosome 14 are very uncommon events, and only four such cases were reported with recombinant progeny [38,45,57]. Unbalanced chromosomal recombination results from crossing over within a pericentric inversion in acrocentric chromosomes under specific conditions. However, duplications and deficiencies of the acrocentric short arm have little or no phenotype impact. Congenital anomalies in an individual with a recombined inverted acrocentric chromosome can be attributed specifically to either partial duplication or deletion of the specific chromosomal long arm. It is interesting to find that breakpoints, size of duplicated segment, and the involved genes vary among patients with this chromosomal rearrangement. Eight cases (10%) reported de novo tandem duplication. Intrachromosomal or extrachromosomal duplications are very frequent in the human genome; however, intrachromosomal duplications of the same chromosomal segment (tandem duplications), which can be serial (direct) or inverted (mirror), are infrequent in chromosome 14q [15,21]. Only one case of insertion (2%) was reported [29]. The breakpoints are variable, and the genetic heterogeneity may explain the lack of a well-defined clinical syndrome [32].
The clinical features of the present case were compared with those described in the literature to identify a minimal overlapping region characterized from a molecular genetics perspective, including disease-associated genes. First, heterozygous FRMD4A and TBX1 variants on chromosomes 10 and 22, respectively, identified in both affected siblings were excluded as a cause of clinical manifestations because these genes act in an autosomal recessive manner. Second, sequence mutations in some genes located on 14q have been reported in disease syndromes (such as Krabbe disease, spinocerebellar ataxia with axonal neuropathy, and Leber congenital amaurosis) [45], but the phenotype of our cases does not match with the studies reported previously. Similarly, two protein-coding genes, BEGAIN and AHNAK2, located on this region have yet to be linked to clinical manifestations in both affected cases, and these two genes and their associated clinical symptoms were not described in OMIM or elsewhere. However, the distal region of chromosome 14q32 duplicated in our cases involves nearly 120 genes according to Ensembl Genome Browser, and duplicated segments between 14q32and 14q33 were frequently reported by DECIPHER’s genome database and ClinVar. As a result, several protein-coding genes associated with DD identified by DECIPHER’s genome browser were expected to be related to DD/ID, GR, and facial dysmorphism (https://decipher.sanger.ac.uk/browser#q/12:66711-3409277/location/12:1-7952122; accessed on 2 April 2021) [58]. Five out of 15 candidate genes were associated with the clinical phenotypes in our cases (Table 1).
Particularly, heterozygous mutations in the BCL11B gene located on chr14:99,169,286-99,272,196 (OMIM #618092) can induce DD/ID with speech delay, dysmorphic facies, and T-cell abnormalities [59,60]. Heterozygous mutations in the CCNK gene located on chr14:99,481,408-99,512,439 (OMIM #618147) can lead to DD/ID with hypertelorism and distinctive facies [61]. Heterozygous mutation involving the YY1 gene located on chr14:100,239,143-100,282,787 (OMIM #617557) can cause Gabriele-de Vries syndrome, characterized by mild-to-profound DD/ID in all affected individuals and a broad spectrum of morphological and functional abnormalities [62]. Heterozygous mutations in the DYNC1H1 gene located on chr14:101,964,572-102,056,442 (OMIM #614563) can lead to autosomal dominant mental retardation-13 with cerebral cortical malformations or microcephaly [63,64]. Heterozygous mutations involving the PACS2 gene located on chr14:105,300,717-105,398,146 (OMIM #618067) cause developmental and epileptic encephalopathy-66 with facial dysmorphism and cerebellar dysgenesis, characterized by the onset of various types of seizures in the first days or weeks of life [65]. However, these curated genes/regions are not predicted to be dosage-sensitive according to ClinGen Dosage Sensitivity Map: ClinGen Triplosensitivity Score for the TECPR2 gene is 0 and 14 other genes are awaiting review (https://dosage.clinicalgenome.org/; accessed on 30 August 2021) (Figure 5).
On the other hand, imprinted regions were identified at 14q32 in the duplicated segment. The imprinted genes may be maternal (MEG3 and MEG8) or paternal inherited (DLK1 and RTL1) [66]. Consistent with these findings, both paternal and maternal uniparental disomies for chromosome 14 cause distinct clinical features. However, our cases were not affected by uniparental disomy. No substantial differences in the clinical manifestations were found, underlining the lack of imprinted gene contribution in the phenotypic features [39]. Furthermore, the gene-regulatory interactions and the epigenetic mechanisms are not understood completely, and their role in the clinical symptoms remains unknown.

6. Conclusions

In the present study, the proband with DD/ID, GR, and facial dysmorphism showed CI, and her elder brother carried a history of suspected perinatal CI, in contrast to previous reports. Although the parents had normal chromosomes, two affected cases carrying terminal duplication of 14q32 can be explained by gonadal mosaicism. The proportion of abnormal germ cells is determined by the mutations early in germ cell differentiation. Further studies are needed to establish the association between cerebrovascular events and terminal duplication of chromosome 14q32, including investigation into the cytogenetics of patients with precise clinical descriptions.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/genes12091388/s1, Table S1: Detailed rearranged region of chromosome 14q and clinical magnifications from literature review in patients with 14q duplication.

Author Contributions

Conceptualization, J.Y.H.; Data curation, J.Y.H.; Formal analysis, J.Y.H. and J.P.; Writing—original draft preparation, J.Y.H.; Writing—review and editing, J.P.; Supervision, J.P.; Funding acquisition, J.Y.H. and J.P. Both authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT; 2021RIF1A063568).

Institutional Review Board Statement

This study was approved by the Daejeon St. Mary’s Hospital, The Catholic University of Korea institutional review board (Approval number: DC18ZESI0048; Date of approval: 30 April 2018).

Informed Consent Statement

The participant and the parents provided written informed consent for clinical and molecular analyses. Patient consent for publication of medical information was obtained from the participants’ parents and/or guardians.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

This study makes use of data generated by the DECIPHER community. A full list of centres contributing to data generation is available from https://deciphergenomics.org/about/stats (accessed on 2 April 2021) and via email from [email protected]. Funding for the DECIPHER project was provided by Wellcome.

Conflicts of Interest

The authors have no conflict of interest to declare.

References

  1. Heilig, R.; Eckenberg, R.; Petit, J.L.; Fonknechten, N.; Da Silva, C.; Cattolico, L.; Levy, M.; Barbe, V.; de Berardinis, V.; Ureta-Vidal, A.; et al. The DNA sequence and analysis of human chromosome 14. Nature 2003, 421, 601–607. [Google Scholar] [CrossRef]
  2. Lupski, J.R.; Stankiewicz, P. Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet. 2005, 1, e49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Gonzales, P.R.; Carroll, A.J.; Korf, B.R. Overview of Clinical Cytogenetics. Curr. Protoc. Hum. Genet. 2016, 89, 8.1.1–8.1.13. [Google Scholar] [CrossRef] [PubMed]
  4. Harewood, L.; Fraser, P. The impact of chromosomal rearrangements on regulation of gene expression. Hum. Mol. Genet. 2014, 23, R76–R82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Allderdice, P.W.; Miller, O.J.; Miller, D.A.; Breg, W.R.; Gendel, E.; Zelson, C. Familial translocation involving chromosomes 6, 14 and 20, identified by quinacrine fluorescence. Humangenetik 1971, 13, 205–209. [Google Scholar] [CrossRef] [PubMed]
  6. Reiss, J.A.; Wyandt, H.E.; Magenis, R.E.; Lovrien, E.W.; Hecht, F. Mosaicism with translocation: Autoradiographic and fluorescent studies of an inherited reciprocal translocation t(2q+;14q-). J. Med. Genet. 1972, 9, 280–286. [Google Scholar] [CrossRef] [Green Version]
  7. Short, E.M.; Solitare, G.B.; Breg, W.R. A case of partial 14 trisomy 47,XY,(14q-)+ and translocation t(9p+;14q-) in mother and brother. J. Med. Genet. 1972, 9, 367–373. [Google Scholar] [CrossRef] [Green Version]
  8. Pfeiffer, R.A.; Buttinghaus, K.; Struck, H. Partial trisomy 14 following a balanced reciprocal translocation t(14q-;21q+). Humangenetik 1973, 20, 187–189. [Google Scholar] [CrossRef]
  9. Fryns, J.P.; Cassiman, J.J.; Van den Berghe, H. Tertiary partial 14 trisomy 47, XX, plus 14q minus. Humangenetik 1974, 24, 71–77. [Google Scholar] [CrossRef]
  10. Wahlstrom, J. A prenatally discovered unbalanced translocation t(14;22) (q22 or 23;q13). Hereditas 1974, 78, 251–254. [Google Scholar] [CrossRef]
  11. Raoul, O.; Rethoré, M.O.; Dutriliaux, B.; Michon, L.; Lejeune, J. [Partial 14q trisomy. I. Partial 14q trisomy by maternal translocation t(10;14) (p15.2;q22)]. Ann. Genet. 1975, 18, 35–39. [Google Scholar] [PubMed]
  12. Fryns, J.P.; Van Eygen, M.; Tanghe, W.; Van Den Berghe, H. Partial trisomy 14q due to familial t(14q-,11q+) translocation. Hum. Genet. 1977, 37, 105–110. [Google Scholar] [CrossRef] [PubMed]
  13. Simpson, J.; Zellweger, H. Partial trisomy 14q -- and parental translocation of No. 14 chromosome. Report of a case and review of the literature. J. Med. Genet. 1977, 14, 124–127. [Google Scholar] [CrossRef] [PubMed]
  14. Trunca, C.; Opitz, J.M. Pericentric inversion of chromosome 14 and the risk of partial duplication of 14q (14q31 leads to 14qter). Am. J. Med. Genet. 1977, 1, 217–228. [Google Scholar] [CrossRef]
  15. Pfeiffer, R.A.; Kessel, E. Balanced and unbalanced pericentric inversion of a chromosome 14. Hum. Genet. 1978, 43, 103–106. [Google Scholar] [CrossRef]
  16. Bridgman, G.; Butler, L.J. A child trisomic for the distal part of chromosome 14q. Arch. Dis. Child. 1980, 55, 474–477. [Google Scholar] [CrossRef] [Green Version]
  17. Geormaneanu, M.; Geormaneanu, C.; Walter-Rosianu, A.; Papuc, M. [Distal trisomy 14q associated with agenesis of the corpus callosus and truncus arteriosus due to the maternal translocation t(5;14)(q13;q23q32) (author's transl)]. Ann. Genet. 1981, 24, 176–178. [Google Scholar]
  18. Sklower, S.; Jenkins, E.; Nolin, S.; Warburton, D.; Yaboa, K.; Merkrebs, A.; Schwartz, R.; Wisniewski, K.; Stimson, C.; Brown, T. Familial distal trisomy 14q. Am. J. Hum. Genet. 1982, 34, 145A. [Google Scholar]
  19. Atkin, J.F.; Patil, S. Duplication of the distal segment of 14q. Am. J. Med. Genet. 1983, 16, 357–366. [Google Scholar] [CrossRef]
  20. Cohen, M.M.; Charrow, J.; Balkin, N.E.; Harris, C.J. Partial trisomy 14 (q23 leads to qter) via segregation of a 14/X translocation. Am. J. Hum. Genet. 1983, 35, 635–644. [Google Scholar]
  21. Nikolis, J.; Ivanovic, K.; Kosanovic, M. Tandem duplication of chromosome 14 (q24 leads to q32) in male newborn with congenital malformations. Clin. Genet. 1983, 23, 321–324. [Google Scholar] [PubMed]
  22. Orye, E.; Van Bever, H.; Desimpel, H. Distal trisomy 14q due to tandem duplication (q24 leads to q32). Ann. Genet. 1983, 26, 238–239. [Google Scholar] [PubMed]
  23. Romain, D.R.; Columbano-Green, L.M.; Smythe, R.H.; Parfitt, R.G.; Gebbie, O.; Chapman, C.J.; Wall, M. Partial trisomy 14q24 leads to qter. J. Med. Genet. 1983, 20, 466–467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Turleau, C.; de Grouchy, J.; Chavin-Colin, F.; Denavit, M.F.; Le Touze, P. [Distal 14q trisomy]. Ann. Genet. 1983, 26, 165–170. [Google Scholar]
  25. Kaiser, P.; Forster, W.; Steuernagel, P.; Hillig, U.; Herberg, K.P. Familial pericentric inversion (14) (p11;q24) with a rec dup(q) in one offspring. Clin. Genet. 1984, 26, 73–76. [Google Scholar] [CrossRef]
  26. Markkanen, A.; Somer, M.; Nordstrom, A.M. Distal trisomy 14q syndrome; a case report. Clin. Genet. 1984, 26, 231–234. [Google Scholar] [CrossRef]
  27. Sklower, S.L.; Jenkins, E.C.; Nolin, S.L.; Duncan, C.J.; Warburton, D.; Yeboa, K.A.; Merkrebs, A.; Schwartz, R.; Wisniewski, K.; Stimson, C.; et al. Distal duplication 14q: Report of three cases and further delineation of the syndrome. Hum. Genet. 1984, 68, 159–164. [Google Scholar] [CrossRef]
  28. Carr, D.M.; Jones-Quartey, K.; Vartanian, M.V.; Moore-Kaplan, H. Duplication 14(q31----qter). J. Med. Genet. 1987, 24, 372–374. [Google Scholar] [CrossRef]
  29. Mikelsaar, R.V.; Ilus, T.A.; Lurie, I.W. Distal trisomy 14q. J. Med. Genet. 1987, 24, 380–381. [Google Scholar] [CrossRef] [Green Version]
  30. Wakita, Y.; Narahara, K.; Kikkawa, K.; Namba, H.; Hiramoto, K.; Eguchi, K.; Matsubara, T.; Kimoto, H. Distal 14q trisomy syndrome in two siblings: Further delineation of its phenotype. Jinrui idengaku zasshi. Jpn. J. Hum. Genet. 1988, 33, 469–475. [Google Scholar] [CrossRef] [Green Version]
  31. Masada, C.T.; Olney, A.H.; Fordyce, R.; Sanger, W.G. Partial deletion of 14q and partial duplication of 14q in sibs: Testicular mosaicism for t(14q;14q) as a common mechanism. Am. J. Med. Genet. 1989, 34, 528–534. [Google Scholar] [CrossRef]
  32. Gilgenkrantz, S.; Vigneron, J.; Peter, M.O.; Dufier, J.L.; Teboul, M.; Chery, M.; Keyeux, G.; Lefranc, M.P. Distal trisomy 14q. I. Clinical and cytogenetical studies. Hum. Genet. 1990, 85, 612–616. [Google Scholar] [CrossRef]
  33. Nakamura, Y.; Sakai, K.; Sakuma, S.; Sato, E.; Maruyama, M.; Hashimoto, T.; Fukuda, S.; Nishimi, Y.; Nakagome, Y.; Nakahori, Y.; et al. Partial trisomy of the distal segment 14q. Hum. Genet. 1990, 84, 574–576. [Google Scholar] [CrossRef]
  34. Carter, N.P.; Ferguson-Smith, M.A.; Perryman, M.T.; Telenius, H.; Pelmear, A.H.; Leversha, M.A.; Glancy, M.T.; Wood, S.L.; Cook, K.; Dyson, H.M.; et al. Reverse chromosome painting: A method for the rapid analysis of aberrant chromosomes in clinical cytogenetics. J. Med. Genet. 1992, 29, 299–307. [Google Scholar] [CrossRef]
  35. Mignon-Ravix, C.; Mugneret, F.; Stavropoulou, C.; Depetris, D.; Khau Van Kien, P.; Mattei, M.G. Maternally inherited duplication of the possible imprinted 14q31 region. J. Med. Genet. 2001, 38, 343–347. [Google Scholar] [CrossRef] [Green Version]
  36. Orellana, C.; Martinez, F.; Badia, L.; Millan, J.M.; Montero, M.R.; Andres, J.; Prieto, F. Trisomy rescue by postzygotic unbalanced (X;14) translocation in a girl with dysmorphic features. Clin. Genet. 2001, 60, 206–211. [Google Scholar] [CrossRef]
  37. Perrin, Y.; Addor, M.C.; Sekarski, N.; Gaide, A.C.; Schorderet, D.F. Distal trisomy 14 (q24 --> qter) and aorto-pulmonary window: A case report and review of the literature. Ann. Genet. 2002, 45, 173–175. [Google Scholar] [CrossRef]
  38. Sonoda, T.; Kouno, K.; Sawada, K.; Sugimoto, T. Distal 14q trisomy due to a maternal derivative chromosome 14. Pediatr. Int. Off. J. Jpn. Pediatr. Soc. 2001, 43, 313–315. [Google Scholar] [CrossRef] [PubMed]
  39. Sutton, V.R.; Coveler, K.J.; Lalani, S.R.; Kashork, C.D.; Shaffer, L.G. Subtelomeric FISH uncovers trisomy 14q32: Lessons for imprinted regions, cryptic rearrangements and variant acrocentric short arms. Am. J. Med. Genet. 2002, 112, 23–27. [Google Scholar] [CrossRef] [PubMed]
  40. Chen, C.P.; Chern, S.R.; Lin, S.P.; Lin, C.C.; Li, Y.C.; Wang, T.H.; Lee, C.C.; Pan, C.W.; Hsieh, L.J.; Wang, W. A paternally derived inverted duplication of distal 14q with a terminal 14q deletion. Am. J. Med. Genet. Part A 2005, 139a, 146–150. [Google Scholar] [CrossRef]
  41. Šliužas, V.; Utkus, A.; Kučinskas, V. Recombinant chromosome 14 due to maternal pericentric inversion. J. Appl. Genet. 2008, 49, 205–207. [Google Scholar] [CrossRef] [PubMed]
  42. Thiel, C.T.; Dorr, H.G.; Trautmann, U.; Hoyer, J.; Hofmann, K.; Kraus, C.; Ekici, A.B.; Reis, A.; Rauch, A. A de novo 7.6Mb tandem duplication of 14q32.2-qter associated with primordial short stature with neurosecretory growth hormone dysfunction, distinct facial anomalies and mild developmental delay. Eur. J. Med. Genet. 2008, 51, 362–367. [Google Scholar] [CrossRef] [PubMed]
  43. Pallister, P.D.; Pallister, A.B.; South, S.; Toydemir, R.; Johnson, J.P.; Beischel, L.; Opitz, J.M. A deletion 13q34/duplication 14q32.2-14q32.33 syndrome diagnosed 50 years after neonatal presentation as infantile hypercalcemia. Am. J. Med. Genet. Part A 2011, 155a, 833–839. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, C.P.; Hwang, K.S.; Su, H.Y.; Lin, S.P.; Su, Y.N.; Chern, S.R.; Su, J.W.; Chen, Y.T.; Chen, W.L.; Wang, W. Prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial duplication of 14q (14q31.3-->q32.12) associated with abnormal maternal serum biochemistry. Taiwan. J. Obstet. Gynecol. 2013, 52, 125–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Sgardioli, I.C.; Simioni, M.; Viguetti-Campos, N.L.; Prota, J.R.; Gil-da-Silva-Lopes, V.L. A new case of partial 14q31.3-qter trisomy due to maternal pericentric inversion. Gene 2013, 523, 192–194. [Google Scholar] [CrossRef] [Green Version]
  46. Chen, C.P.; Lin, C.J.; Chern, S.R.; Wu, P.S.; Chen, Y.N.; Chen, S.W.; Lee, C.C.; Chen, L.F.; Yang, C.W.; Wang, W. Prenatal diagnosis and molecular cytogenetic characterization of a de novo unbalanced reciprocal translocation of der(9)t(9;14)(p24.2;q32.11) associated with 9p terminal deletion and 14q distal duplication. Taiwan. J. Obstet. Gynecol. 2016, 55, 596–601. [Google Scholar] [CrossRef] [Green Version]
  47. He, C.; Dong, C.; Li, J.; Hu, D.; Yao, L.; Wu, Y. A Familial 14q32.32q32.33 Duplication/17p13.3 Deletion Syndrome with Facial Anomalies and Moderate Intellectual Disability. Cytogenet. Genome Res. 2016, 148, 262–267. [Google Scholar] [CrossRef]
  48. Santoro, S.; Bao, L.; Saal, H.M. Terminal 14q Deletion and Duplication with Gastrointestinal and Pulmonary Disease. Pediatr Neonatal Care 2016, 5, 00174. [Google Scholar] [CrossRef]
  49. Villa, N.; Scatigno, A.; Redaelli, S.; Conconi, D.; Cianci, P.; Farina, C.; Fossati, C.; Dalpra, L.; Maitz, S.; Selicorni, A. 14q32.3-qter trisomic segment: A case report and literature review. Mol. Cytogenet. 2016, 9, 60. [Google Scholar] [CrossRef] [Green Version]
  50. Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405–424. [Google Scholar] [CrossRef] [PubMed]
  51. Dong, X.; Liu, B.; Yang, L.; Wang, H.; Wu, B.; Liu, R.; Chen, H.; Chen, X.; Yu, S.; Chen, B.; et al. Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: A Chinese cohort. J. Med. Genet. 2020, 57, 558–566. [Google Scholar] [CrossRef] [Green Version]
  52. Suzuki, H.; Yamada, M.; Uehara, T.; Takenouchi, T.; Kosaki, K. Parallel detection of single nucleotide variants and copy number variants with exome analysis: Validation in a cohort of 700 undiagnosed patients. Am. J. Med. Genet. Part A 2020, 182, 2529–2532. [Google Scholar] [CrossRef] [PubMed]
  53. Li, C.; Vandersluis, S.; Holubowich, C.; Ungar, W.J.; Goh, E.S.; Boycott, K.M.; Sikich, N.; Dhalla, I.; Ng, V. Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies. Genet. Med. 2021, 23, 451–460. [Google Scholar] [CrossRef] [PubMed]
  54. Pugh, T.J.; Amr, S.S.; Bowser, M.J.; Gowrisankar, S.; Hynes, E.; Mahanta, L.M.; Rehm, H.L.; Funke, B.; Lebo, M.S. VisCap: Inference and visualization of germ-line copy-number variants from targeted clinical sequencing data. Genet. Med. 2016, 18, 712–719. [Google Scholar] [CrossRef] [Green Version]
  55. Shaw-Smith, C.; Redon, R.; Rickman, L.; Rio, M.; Willatt, L.; Fiegler, H.; Firth, H.; Sanlaville, D.; Winter, R.; Colleaux, L.; et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J. Med. Genet. 2004, 41, 241–248. [Google Scholar] [CrossRef] [Green Version]
  56. Jang, W.; Kim, Y.; Han, E.; Park, J.; Chae, H.; Kwon, A.; Choi, H.; Kim, J.; Son, J.O.; Lee, S.J.; et al. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea. Ann. Lab. Med. 2019, 39, 299–310. [Google Scholar] [CrossRef]
  57. Leach, N.T.; Cole, S.M.; Sandstrom, D.J.; Weremowicz, S. A novel pericentric inversion of chromosome 14 involving the rRNA gene cluster. Prenat. Diagn. 2005, 25, 620–621. [Google Scholar] [CrossRef]
  58. Firth, H.V.; Richards, S.M.; Bevan, A.P.; Clayton, S.; Corpas, M.; Rajan, D.; Van Vooren, S.; Moreau, Y.; Pettett, R.M.; Carter, N.P. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 2009, 84, 524–533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Lessel, D.; Gehbauer, C.; Bramswig, N.C.; Schluth-Bolard, C.; Venkataramanappa, S.; van Gassen, K.L.I.; Hempel, M.; Haack, T.B.; Baresic, A.; Genetti, C.A.; et al. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain 2018, 141, 2299–2311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Qiao, F.; Wang, C.; Luo, C.; Wang, Y.; Shao, B.; Tan, J.; Hu, P.; Xu, Z. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing. Mol. Genet. Genomic Med. 2019, 7, e897. [Google Scholar] [CrossRef] [Green Version]
  61. Fan, Y.; Yin, W.; Hu, B.; Kline, A.D.; Zhang, V.W.; Liang, D.; Sun, Y.; Wang, L.; Tang, S.; Powis, Z.; et al. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism. Am. J. Hum. Genet. 2018, 103, 448–455. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Gabriele, M.; Vulto-van Silfhout, A.T.; Germain, P.L.; Vitriolo, A.; Kumar, R.; Douglas, E.; Haan, E.; Kosaki, K.; Takenouchi, T.; Rauch, A.; et al. YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction. Am. J. Hum. Genet. 2017, 100, 907–925. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Willemsen, M.H.; Vissers, L.E.; Willemsen, M.A.; van Bon, B.W.; Kroes, T.; de Ligt, J.; de Vries, B.B.; Schoots, J.; Lugtenberg, D.; Hamel, B.C.; et al. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J. Med. Genet. 2012, 49, 179–183. [Google Scholar] [CrossRef]
  64. Poirier, K.; Lebrun, N.; Broix, L.; Tian, G.; Saillour, Y.; Boscheron, C.; Parrini, E.; Valence, S.; Pierre, B.S.; Oger, M.; et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat. Genet. 2013, 45, 639–647. [Google Scholar] [CrossRef]
  65. Olson, H.E.; Jean-Marçais, N.; Yang, E.; Heron, D.; Tatton-Brown, K.; van der Zwaag, P.A.; Bijlsma, E.K.; Krock, B.L.; Backer, E.; Kamsteeg, E.J.; et al. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am. J. Hum. Genet. 2018, 102, 995–1007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Beygo, J.; Küchler, A.; Gillessen-Kaesbach, G.; Albrecht, B.; Eckle, J.; Eggermann, T.; Gellhaus, A.; Kanber, D.; Kordaß, U.; Lüdecke, H.J.; et al. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome. Eur. J. Hum. Genet. 2017, 25, 935–945. [Google Scholar] [CrossRef] [PubMed]
Genes 12 01388 g001 550
Figure 1. Pedigree analysis, clinical imaging, and brain magnetic resonance imaging (MRI) and angiography (MRA) in the proband (II-4) and her elder brother (II-3). (A) Pedigree analysis and clinical photography. (Upper panel) Family pedigree shows a recurrent and dominant de novo duplication of 14q32.11-q32.33 in Korean siblings associated with intellectual disability, growth retardation, facial dysmorphism, and cerebral infarction. (Lower panel) A dysmorphic face characterized by frontal bossing, widely spaced teeth, broad upper alveolar ridges, broad mouth, downturned corners of the mouth, broad nasal root, and deep nasal bridge. (B) The proband showed acute infarction in the right striatocapsular region and cortical area of the right temporal lobe (a and b). The proximal M1 segment of right MCA was occluded, and the distal MCA was retrograde filled by leptomeningeal collaterals (c and d). (C) Her elder brother showed abnormal development of the right hemisphere combined with cortical dysplasia (a and b) and dysgenesis of the corpus callosum (c and d).
Figure 1. Pedigree analysis, clinical imaging, and brain magnetic resonance imaging (MRI) and angiography (MRA) in the proband (II-4) and her elder brother (II-3). (A) Pedigree analysis and clinical photography. (Upper panel) Family pedigree shows a recurrent and dominant de novo duplication of 14q32.11-q32.33 in Korean siblings associated with intellectual disability, growth retardation, facial dysmorphism, and cerebral infarction. (Lower panel) A dysmorphic face characterized by frontal bossing, widely spaced teeth, broad upper alveolar ridges, broad mouth, downturned corners of the mouth, broad nasal root, and deep nasal bridge. (B) The proband showed acute infarction in the right striatocapsular region and cortical area of the right temporal lobe (a and b). The proximal M1 segment of right MCA was occluded, and the distal MCA was retrograde filled by leptomeningeal collaterals (c and d). (C) Her elder brother showed abnormal development of the right hemisphere combined with cortical dysplasia (a and b) and dysgenesis of the corpus callosum (c and d).
Genes 12 01388 g001
Genes 12 01388 g002 550
Figure 2. Results of chromosomal analysis in the proband and her family members. Chromosomal analysis revealed 46,XX,der(14)t(14;14)(p11.2;q32.1) in the proband (A) and 46,XY,der(14)t(14;14)(p11.2;q32.1) in her elder brother (B) as indicated by the red arrow, respectively. However, their father (C) and mother (D) showed normal karyotyping.
Figure 2. Results of chromosomal analysis in the proband and her family members. Chromosomal analysis revealed 46,XX,der(14)t(14;14)(p11.2;q32.1) in the proband (A) and 46,XY,der(14)t(14;14)(p11.2;q32.1) in her elder brother (B) as indicated by the red arrow, respectively. However, their father (C) and mother (D) showed normal karyotyping.
Genes 12 01388 g002
Genes 12 01388 g003 550
Figure 3. Results of coverage analysis based on duo exome sequencing, and chromosomal microarray in the proband (II-4) and her elder brother (II-3). (A) Copy number analysis using duo exome sequencing revealed 14q32.11-q32.33 duplication in the proband (II-4) and her elder brother (II-3), as highlighted in the red box. (B) Chromosomal microarray established a gain of 17.2 Mb from 14q32.11 to 14qter in the proband (II-4) and her elder brother (II-3). The arr[hg19]14q32.11q32.33(90,043,558_107,258,824)x3 is highlighted in the red box.
Figure 3. Results of coverage analysis based on duo exome sequencing, and chromosomal microarray in the proband (II-4) and her elder brother (II-3). (A) Copy number analysis using duo exome sequencing revealed 14q32.11-q32.33 duplication in the proband (II-4) and her elder brother (II-3), as highlighted in the red box. (B) Chromosomal microarray established a gain of 17.2 Mb from 14q32.11 to 14qter in the proband (II-4) and her elder brother (II-3). The arr[hg19]14q32.11q32.33(90,043,558_107,258,824)x3 is highlighted in the red box.
Genes 12 01388 g003
Genes 12 01388 g004 550
Figure 4. Literature review of the clinical features and frequencies of 14q duplication in 45 reported cases attributed to translocation, tandem duplication, inversion, or insertion [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]. Blue bar, detailed phenotypes of growth and development; green bar, detailed phenotypes of facial dysmorphisms; orange bar, detailed phenotypes of other organ system anomalies; grey bar, detailed phenotypes of other problems; DD, developmental delay; ID, intellectual disability.
Figure 4. Literature review of the clinical features and frequencies of 14q duplication in 45 reported cases attributed to translocation, tandem duplication, inversion, or insertion [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]. Blue bar, detailed phenotypes of growth and development; green bar, detailed phenotypes of facial dysmorphisms; orange bar, detailed phenotypes of other organ system anomalies; grey bar, detailed phenotypes of other problems; DD, developmental delay; ID, intellectual disability.
Genes 12 01388 g004
Genes 12 01388 g005 550
Figure 5. Schematic representation of previously reported cases spanning the terminal 17.2 Mb of chromosome 14q32, including ClinGen Dosage Sensitivity Map and Copy Number variation Morbidity Map of Developmental Delay displayed by UCSC Genome Browser (http://genome.ucsc.edu/; accessed on 30 August 2021). Blue bars indicate pathogenic or related gains based on copy number variation morbidity map of developmental delay.
Figure 5. Schematic representation of previously reported cases spanning the terminal 17.2 Mb of chromosome 14q32, including ClinGen Dosage Sensitivity Map and Copy Number variation Morbidity Map of Developmental Delay displayed by UCSC Genome Browser (http://genome.ucsc.edu/; accessed on 30 August 2021). Blue bars indicate pathogenic or related gains based on copy number variation morbidity map of developmental delay.
Genes 12 01388 g005
Table
Table 1. Fifteen candidate genes associated with developmental delay located between 14q32 and 14q33.
Table 1. Fifteen candidate genes associated with developmental delay located between 14q32 and 14q33.
DD GenesMorbidityDiseasesOMIMInheritance
CCDC88CYesHydrocephalus, congenital, 1# 236600AR
TRIP11YesAchondrogenesis, type IA
Odontochondrodysplasia 1		# 200600
# 184260		AR
SLC24A4YesAmelogenesis imperfecta, type IIA5# 615887AR
TMEM251YesDysostosis multiplex, Ain-Naz type# 619345AR
UBR7YesLi-Campeau syndrome# 619189AR
VRK1YesPontocerebellar hypoplasia type 1A# 607596AR
BCL11BYesIntellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities# 618092AD
CCNKYesIntellectual developmental disorder with hypertelorism and distinctive facies# 618147AD
YY1YesGabriele-de Vries syndrome# 617557AD
DYNC1H1YesMental retardation, autosomal dominant 13# 614563AD
TECPR2YesSpastic paraplegia 49, autosomal recessive# 615031AR
APOPT1YesMitochondrial complex IV deficiency, nuclear type 17# 619061AR
AKT1YesCowden syndrome 6# 615109AD
BRF1YesCerebellofaciodental syndrome# 616202AR
PACS2YesDevelopmental and epileptic encephalopathy 66# 618067AD
DD, developmental delay; OMIM, Online Mendelian Inheritance in Man; #, a number sign in OMIM; AR, autosomal recessive; AD, autosomal dominant.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Han, J.Y.; Park, J. A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review. Genes 2021, 12, 1388. https://doi.org/10.3390/genes12091388

AMA Style

Han JY, Park J. A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review. Genes. 2021; 12(9):1388. https://doi.org/10.3390/genes12091388

Chicago/Turabian Style

Han, Ji Yoon, and Joonhong Park. 2021. "A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review" Genes 12, no. 9: 1388. https://doi.org/10.3390/genes12091388

APA Style

Han, J. Y., & Park, J. (2021). A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review. Genes, 12(9), 1388. https://doi.org/10.3390/genes12091388

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop